The Venture Codex Logo

The Venture Codex

Overview

Innovative CRO offering disease-oriented R&D solutions for pharmaceuticals.

Founded

2008

Deals · 12mo

0

Stage focus

—

Geographic focus

United States

Sector focus

Biopharma
Pharmaceutical

Investment portfolio

1rounds
NAMEDATESIZE
Xellar Biosystems
Jul 2024Led
$14 MOther Equity
Xellar Biosystems
Jul 2024Led
$14 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

TriApex Laboratories: 1 funding rounds are recorded in the selected participation categories.All available history.
TriApex Laboratories: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity10

Monthly Deal Activity

TriApex Laboratories: 1 deals are recorded across 28 months.All available history.
TriApex Laboratories: 1 deals are recorded across 28 months. All available history
MonthDeals
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

TriApex Laboratories: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

TriApex Laboratories: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1
AI & Machine Learning1

Deal Size Distribution

TriApex Laboratories: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

TriApex Laboratories: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

TriApex Laboratories: United States has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

TriApex Laboratories: United States has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
United States1
TriApex Laboratories: 2 co-investors are shown, with Legend Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

TriApex Laboratories: 2 co-investors are shown, with Legend Capital sharing 1 recorded deals. All available history
Co-investorShared deals
Legend Capital1
Tiantu Capital1

Investment Strategy

TriApex Laboratories: Led accounts for 100% and participating for 0% of round participation.All available history.
TriApex Laboratories: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
TriApex Laboratories: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
TriApex Laboratories: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

No team members found for this fund.